Page last updated: 2024-08-25

isoalantolactone and Endometrial Neoplasms

isoalantolactone has been researched along with Endometrial Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hu, F; Yang, P	1

Other Studies

1 other study(ies) available for isoalantolactone and Endometrial Neoplasms

Article	Year
Isoalantolactone exerts anticancer effects on human HEC-1-B endometrial cancer cells via induction of ROS mediated apoptosis and inhibition of MEK/ERK signalling pathway. Acta biochimica Polonica, 2022, Jun-08, Volume: 69, Issue:2 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Reactive Oxygen Species; Sesquiterpenes	2022

Article

Year

Isoalantolactone exerts anticancer effects on human HEC-1-B endometrial cancer cells via induction of ROS mediated apoptosis and inhibition of MEK/ERK signalling pathway.

Acta biochimica Polonica, 2022, Jun-08, Volume: 69, Issue:2

Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Reactive Oxygen Species; Sesquiterpenes

2022